Vistagen Therapeutics, Inc. (VTGN)
Data as of , from SEC Form 4 filings.
See up to 3 months of VTGN. The 7-day demo opens the 1M and 3M ranges and puts VTGN on your watchlist.
Start 7-day demoLatest VTGN insider trades
- Douglas J. Williamson - DirectorGrant or award40,826 sh
Reid G. Adler - OfficerGrant or award$7K- Nick B. Tressler - Officer
About Vistagen Therapeutics, Inc. (VTGN)
Vistagen Therapeutics, Inc. files with the SEC under CIK 0001411685 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
VTGN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 40,826 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
VTGN insider transactions (Form 4)
2421 Form 4 filings on record, the earliest from Jun 30, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Douglas J. Williamson - Director | Grant or award | Stock Options (Right to Buy) | 40,826 | $0.00 | - | |
| Reid G. Adler - Officer | Grant or award | Common Stock | 36,818 | $0.19 | $7K | |
| Nick B. Tressler - Officer | Grant or award | Common Stock | 11,712 | $0.19 | $2K | |
| Shawn Singh - Officer | Grant or award | Common Stock | 36,818 | $0.19 | $7K | |
| Angel S. Angelov - Officer | Grant or award | Stock Option (Right to Buy) | 150,000 | - footnote F2 | - | |
| ||||||
| Nick B. Tressler - Officer | Grant or award | Incentive Stock Option (right to buy) | 75,000 | $0.00 | - | |
| Shawn Singh - Officer | Grant or award | Incentive Stock Option (right to buy) | 3,732 | $0.00 | - | |
| Shawn Singh - Officer | Grant or award | Non-Qualified Stock Option (right to buy) | 71,268 | $0.00 | - | |
| Joshua S. Prince - Officer | Grant or award | Incentive Stock Option (right to buy) | 18,752 | $0.00 | - | |
| Joshua S. Prince - Officer | Grant or award | Non-Qualified Stock Option (right to buy) | 56,248 | $0.00 | - | |
 Elissa S. Cote - Officer | Grant or award | Incentive Stock Option (right to buy) | 75,000 | $0.00 | - | |
| Reid G. Adler - Officer | Grant or award | Incentive Stock Option (right to buy) | 18,753 | $0.00 | - | |
| Reid G. Adler - Officer | Grant or award | Non-Qualified Stock Option (right to buy) | 56,247 | $0.00 | - | |
| Nick B. Tressler - Officer | Grant or award | Common Stock (Right to Buy) | 150,000 | - footnote F2 | - | |
| ||||||
| Paul R. Edick | Grant or award | Stock Option (Right to Buy) | 35,200 | - footnote F1 | - | |
| ||||||
 Mary L. Rotunno - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 17,600 | $0.00 | - | |
 Margaret M. Fitzpatrick - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 17,600 | $0.00 | - | |
 Joanne Curley - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 17,600 | $0.00 | - | |
| Ann Michelle Cunningham - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 17,600 | $0.00 | - | |
 Jon S. Saxe - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 17,600 | $0.00 | - | |
| Joshua S. Prince - Officer | Grant or award | Common Stock | 4,882 | $1.70 | $8K | |
| Reid G. Adler - Officer | Grant or award | Common Stock | 7,541 | $1.70 | $13K | |
 Cynthia Lynn Anderson - Officer | Grant or award | Common Stock | 6,617 | $1.70 | $11K | |
| Shawn Singh - Officer | Grant or award | Common Stock | 7,541 | $1.70 | $13K | |
VTGN insider trading FAQ
What is the latest insider trade for VTGN?
Vistagen Therapeutics, Inc. (VTGN) had 1 insider filing in the last 90 days, with the most recent on 2026-07-31. The full record for VTGN runs to 21 Form 4 filings, the earliest from 2025-06-30. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VTGN stock?
No insider purchases of VTGN were filed in the last 90 days.
How many insiders are selling VTGN stock?
No insider sales of VTGN were filed in the last 90 days.
Where can I see VTGN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VTGN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Douglas J. Williamson view on EDGAR
- - Reid G. Adler view on EDGAR
- - Nick B. Tressler view on EDGAR
- - Shawn Singh view on EDGAR
- - Angel S. Angelov view on EDGAR
- - Nick B. Tressler view on EDGAR
- - Shawn Singh view on EDGAR
- - Joshua S. Prince view on EDGAR
- - Elissa S. Cote view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VTGN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VTGN with a 7-day demo
- VTGN on your watchlist
- Every VTGN Form 4 filing on record
- Up to 3 months of VTGN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
